News
RANI
0.8028
+2.27%
0.0178
Weekly Report: what happened at RANI last week (0803-0807)?
Weekly Report · 2d ago
Rani Therapeutics appoints Michelle Gilson to board
TipRanks · 08/04 12:49
*Rani Therapeutics Appoints Michelle Gilson to Board of Directors
Dow Jones · 08/04 12:00
Press Release: Rani Therapeutics Appoints Michelle Gilson to Board of Directors
Dow Jones · 08/04 12:00
Weekly Report: what happened at RANI last week (0727-0731)?
Weekly Report · 08/03 10:27
Canaccord Genuity Remains a Buy on Rani Therapeutics Holdings (RANI)
TipRanks · 07/30 11:39
Weekly Report: what happened at RANI last week (0720-0724)?
Weekly Report · 07/27 10:32
Sagimet, PNC, United Rentals, Rani, Southern Copper Insider Shake-Up
TipRanks · 07/25 13:01
Top Insider Makes Bold Move on Rani Therapeutics Stock
TipRanks · 07/24 02:03
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 07/22 17:05
Wednesday 7/22 Insider Buying Report: CAG, RANI
NASDAQ · 07/22 14:31
Weekly Report: what happened at RANI last week (0713-0717)?
Weekly Report · 07/20 10:28
Analysts Are Bullish on Top Healthcare Stocks: Intuitive Surgical (ISRG), Abbott Laboratories (ABT)
TipRanks · 07/17 09:50
Analysts Offer Insights on Healthcare Companies: Rani Therapeutics Holdings (RANI) and Fractyl Health, Inc. (GUTS)
TipRanks · 07/16 13:00
Analysts Offer Insights on Healthcare Companies: Rani Therapeutics Holdings (RANI), Urogen Pharma (URGN) and vTv Therapeutics (VTVT)
TipRanks · 07/16 10:50
Rani's RT-114 Oral Capsule Shows Strong Bioavailability In Phase 1a Study; Phase 1b Underway
NASDAQ · 07/15 13:01
Rani Therapeutics Reports Positive Initial Phase 1 Data For RT-114
NASDAQ · 07/15 12:46
Rani Therapeutics reports initial data from RT-114 study
TipRanks · 07/15 12:40
Rani Therapeutics Reports Initial Phase 1 Data Showing Oral RT‑114 Delivered Systemic Exposure Exceeding Matched Subcutaneous Administration, With Safety And Tolerability Consistent With GLP‑1/GLP‑2 Agonist Class
Benzinga · 07/15 12:04
Analysts Are Bullish on These Healthcare Stocks: Abbott Laboratories (ABT), GE Healthcare Technologies Inc (GEHC)
TipRanks · 07/13 16:00
More
Webull provides a variety of real-time RANI stock news. You can receive the latest news about Rani Therapeutics Holdings, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About RANI
Rani Therapeutics Holdings, Inc. is a clinical-stage biotherapeutics company focused on advancing technologies to enable the development of orally administered biologics and drugs. The Company has developed the RaniPill capsule, which is a proprietary and patented platform technology, intended to replace subcutaneous injection or intravenous infusion of biologics and drugs with oral dosing. The RaniPill capsule is designed to deliver a variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. It has two configurations of the platform: the RaniPill GO and the RaniPill HC. The RaniPill GO is designed to deliver up to a 3 mg dose of drug in microtablet form with high bioavailability. It is also developing a high-capacity version of the RaniPill capsule known as the RaniPill HC. Its product candidate pipeline includes obesity programs (RT-114 and RT-116), immunology programs (RT-105 and RT-111) and endocrinology programs (RT-102 and RT-110).